Market revenue in 2023 | USD 311.4 million |
Market revenue in 2030 | USD 501.7 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Malaysia formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Malaysia is rapidly emerging as a promising destination for formulation development outsourcing in the Asia Pacific region. The country's investment in the medical device manufacturing infrastructure resulted in a strong manufacturing base for medical devices, creating significant potential for foreign companies to outsource their formulation development work.
Its strategic location in Southeast Asia and improving regulatory framework for medication development are additional factors contributing to the growth of the outsourcing market. Moreover, the government's initiatives to boost the medical device industry and efforts to develop its biotechnology sector yielded promising results.
Malaysia has several world-class research institutions and specialized facilities for clinical trials, coupled with a skilled workforce and strong intellectual property protection laws, which are driving the growth of the formulation development outsourcing industry.
Horizon Databook provides a detailed overview of country-level data and insights on the Malaysia formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Malaysia formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account